MedPath

Annual changes of pathogen and antimicrobial susceptibility of causative bacteria isolated from patient with cholecystitis, cholangitis, severe acute pancreatitis

Not Applicable
Conditions
Cholecystitis, Cholangitis, severe Acute pancreatitis
Registration Number
JPRN-UMIN000005104
Lead Sponsor
agaoka Chuo Hospital Koseiren, Niigata-Ken
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Cases with severe cardiac, hepatic, renal function disorder (2) Cases with a history of allergy to B-lactam antibiotics (carbapenems,cephems, penicillins, etc) (3) Cases pregnant, lactating or suspected of being pregnant (4) Cases which therapeutic response of B-lactam antibiotics can not be expected (caused by virus, mycoplasma, chlamydia and fungus) (5) Cases treated with sodium valproate or with central nervous system damage such as epilepsia (6) Cases which need combined usage of diuretic such as furosemide (7) Cases with improvement by previous treatment of antimicrobial agent (8) Cases with similar infectious episode of ineffective treatment with carbapenem antibiotics (9) Other cases which doctor in charge regard inadequate to include in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Causative bacteria and antimicrobial susceptibility before and after antimicrobial administration Clinical response and safety of day 3 and day 7 after Biapenem is administered
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath